Adrenal functional reserve in the full spectrum of chronic kidney disease

Gaceta Medica De Mexico
|February 1, 2022
PubMed

Insights

Cortisol levels rise in early chronic kidney disease (CKD) as kidney function declines. This study found no adrenal insufficiency (AI) in CKD patients, suggesting routine AI screening is unnecessary.

Area of Science:

  • Endocrinology
  • Nephrology
  • Internal Medicine

Background:

  • Altered cortisol levels are linked to mortality and reduced quality of life in chronic kidney disease (CKD) patients.
  • Adrenal response to adrenocorticotropic hormone (ACTH) stimulation has not been well-evaluated in stages 3-5 CKD, with or without renal replacement therapy (RRT).

Purpose of the Study:

  • To evaluate adrenal function in patients diagnosed with chronic kidney disease (CKD).

Main Methods:

  • A low-dose cosyntropin (synthetic ACTH) stimulation test was administered to adult CKD patients.
  • Serum cortisol levels were measured at baseline, 30 minutes, and 60 minutes post-stimulation.

Main Results:

  • Sixty participants with stages 3-5 CKD (with/without RRT) were included; none exhibited adrenal insufficiency (AI).
  • A significant negative correlation was found between glomerular filtration rate (GFR) and cortisol levels at baseline, 30 minutes, and 60 minutes post-ACTH stimulation (r: -0.39 to -0.4, p ≤ 0.004).

Conclusions:

  • Cortisol levels increase in early CKD stages as GFR decreases.
  • Systematic screening for adrenal insufficiency (AI) is not deemed necessary for patients with chronic kidney disease (CKD).
Abstract

Related Concept Videos

Factors Affecting Renal Clearance: Renal Impairment01:17

Factors Affecting Renal Clearance: Renal Impairment

Renal dysfunction significantly impairs the renal clearance of drugs, leading to potential complications in drug therapy. Renal failure, which can be caused by various factors, poses a significant challenge in the elimination of drugs from the body.
One condition associated with renal failure is uremia. Uremia is characterized by impaired glomerular filtration and fluid accumulation in the body. This condition hinders the renal clearance of drugs, resulting in drug accumulation and potential...
184
Renal Failure: Dose Adjustments01:11

Renal Failure: Dose Adjustments

In patients with renal impairment, drugs undergo significant changes in their pharmacokinetics, which require dosage adjustments to ensure safe and effective therapy.
Reduced renal clearance and elimination rate are common outcomes of renal impairment. These alterations lead to a prolonged elimination half-life and an altered apparent volume of distribution for drugs. As a result, dosage adjustments are typically necessary to maintain optimal drug levels in the body.
However, dosage adjustments...
182
Chronic Kidney Disease II: Clinical Manifestations01:24

Chronic Kidney Disease II: Clinical Manifestations

Chronic Kidney Disease (CKD) progressively impairs multiple body systems due to the accumulation of uremic toxins, which disrupt cellular functions across various organs.Neurologic symptomsNeurologic symptoms often arise early in CKD, as uremic toxin buildup drives changes in cognitive and motor functions. Patients frequently experience fatigue, headache, confusion, difficulty concentrating, and, in severe cases, seizures. Peripheral neuropathy commonly manifests as burning sensations in the...
136
Chronic Kidney Disease III: Interprofessional Care01:28

Chronic Kidney Disease III: Interprofessional Care

Chronic kidney disease (CKD) requires collaborative and comprehensive management. CKD progresses through stages and can lead to end-stage kidney disease (ESKD) if untreated. Interprofessional collaboration and patient education are crucial, enabling patients to manage their health and improve their quality of life.Diagnostic approach for chronic kidney diseaseThe diagnosis of CKD primarily focuses on the glomerular filtration rate (GFR), which assesses kidney function by measuring how well...
96
Chronic Kidney Disease I: Introduction01:25

Chronic Kidney Disease I: Introduction

Chronic Kidney Disease (CKD) arises when the kidneys progressively lose their ability to function, ultimately leading to end-stage renal disease. At this advanced stage, the kidneys can no longer filter waste or maintain essential body functions, requiring renal replacement therapy (RRT) through dialysis or a kidney transplant for survival.Early-stage chronic kidney disease and detection challengesIn CKD's early stages, symptoms often remain absent because healthy nephrons compensate for...
101
Acute Kidney Injury III: Clinical Manifestations01:29

Acute Kidney Injury III: Clinical Manifestations

Acute Kidney Injury (AKI) progresses through distinct clinical phases: the oliguric, diuretic, and recovery phases, each marked by unique manifestations and challenges.Oliguric Phase:The oliguric phase is the initial stage of AKI, typically lasting 10 to 14 days. This phase is marked by a significant reduction in urine output, usually less than 400 mL per day, indicating decreased kidney function. Fluid retention is a prominent feature, leading to symptoms such as edema, hypertension, and...
140